Cover Image
Market Research Report

Generics Global Industry Guide 2017-2021

Published by MarketLine Product code 251357
Published Content info 247 Pages
Delivery time: 1-2 business days
Back to Top
Generics Global Industry Guide 2017-2021
Published: February 28, 2018 Content info: 247 Pages


Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All currency conversions were calculated at constant average annual 2016 exchange rates.

The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.

Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.

Strong growth will continue in the emerging markets but worldwide there will be a deceleration.


  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
  • Reasons to buy
  • What was the size of the global generics market by value in 2016?
  • What will be the size of the global generics market in 2021?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?
Table of Contents
Product Code: MLIG1744-06

Table of Contents


Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Geography segmentation 2

Introduction 19

What is this report about? 19

Who is the target reader? 19

How to use this report 19

Definitions 19

Global Generics 20

Market Overview 20

Market Data 21

Market Segmentation 23

Market outlook 24

Five forces analysis 26

Generics in Asia-Pacific 32

Market Overview 32

Market Data 33

Market Segmentation 35

Market outlook 36

Five forces analysis 38

Generics in Europe 44

Market Overview 44

Market Data 45

Market Segmentation 47

Market outlook 48

Five forces analysis 50

Generics in France 56

Market Overview 56

Market Data 57

Market Segmentation 59

Market outlook 60

Five forces analysis 62

Macroeconomic indicators 68

Generics in Germany 70

Market Overview 70

Market Data 71

Market Segmentation 73

Market outlook 74

Five forces analysis 76

Macroeconomic indicators 82

Generics in Italy 84

Market Overview 84

Market Data 85

Market Segmentation 87

Market outlook 88

Five forces analysis 90

Macroeconomic indicators 96

Generics in Japan 98

Market Overview 98

Market Data 99

Market Segmentation 101

Market outlook 102

Five forces analysis 104

Macroeconomic indicators 110

Generics in Australia 112

Market Overview 112

Market Data 113

Market Segmentation 115

Market outlook 116

Five forces analysis 118

Macroeconomic indicators 124

Generics in Canada 126

Market Overview 126

Market Data 127

Market Segmentation 129

Market outlook 130

Five forces analysis 132

Macroeconomic indicators 138

Generics in China 140

Market Overview 140

Market Data 141

Market Segmentation 143

Market outlook 144

Five forces analysis 146

Macroeconomic indicators 153

Generics in The Netherlands 155

Market Overview 155

Market Data 156

Market Segmentation 158

Market outlook 159

Five forces analysis 161

Macroeconomic indicators 167

Generics in Spain 169

Market Overview 169

Market Data 170

Market Segmentation 172

Market outlook 173

Five forces analysis 175

Macroeconomic indicators 181

Generics in The United Kingdom 183

Market Overview 183

Market Data 184

Market Segmentation 186

Market outlook 187

Five forces analysis 189

Macroeconomic indicators 195

Generics in The United States 197

Market Overview 197

Market Data 198

Market Segmentation 200

Market outlook 201

Five forces analysis 203

Macroeconomic indicators 209

Company Profiles 211

Leading Companies 211

Appendix 245

Methodology 245

About MarketLine 246

Back to Top